217 related articles for article (PubMed ID: 23401854)
61. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
[TBL] [Abstract][Full Text] [Related]
62. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
Scaglioni PP; Rabellino A; Yung TM; Bernardi R; Choi S; Konstantinidou G; Nardella C; Cheng K; Pandolfi PP
EMBO Mol Med; 2012 Jul; 4(7):594-602. PubMed ID: 22359342
[TBL] [Abstract][Full Text] [Related]
63. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
Volk EL; Fan L; Schuster K; Rehg JE; Harris LC
Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200
[TBL] [Abstract][Full Text] [Related]
64. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
65. Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts.
Suzuki J; Yamazaki Y; Li G; Kaziro Y; Koide H
Mol Cell Biol; 2000 Jul; 20(13):4658-65. PubMed ID: 10848592
[TBL] [Abstract][Full Text] [Related]
66. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
[TBL] [Abstract][Full Text] [Related]
67. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.
Chan JC; Hannan KM; Riddell K; Ng PY; Peck A; Lee RS; Hung S; Astle MV; Bywater M; Wall M; Poortinga G; Jastrzebski K; Sheppard KE; Hemmings BA; Hall MN; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
Sci Signal; 2011 Aug; 4(188):ra56. PubMed ID: 21878679
[TBL] [Abstract][Full Text] [Related]
68. Induction of p38δ expression plays an essential role in oncogenic ras-induced senescence.
Kwong J; Chen M; Lv D; Luo N; Su W; Xiang R; Sun P
Mol Cell Biol; 2013 Oct; 33(19):3780-94. PubMed ID: 23878395
[TBL] [Abstract][Full Text] [Related]
69. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
[TBL] [Abstract][Full Text] [Related]
70. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.
Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M
J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927
[TBL] [Abstract][Full Text] [Related]
71. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
[TBL] [Abstract][Full Text] [Related]
72. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
Huot TJ; Rowe J; Harland M; Drayton S; Brookes S; Gooptu C; Purkis P; Fried M; Bataille V; Hara E; Newton-Bishop J; Peters G
Mol Cell Biol; 2002 Dec; 22(23):8135-43. PubMed ID: 12417717
[TBL] [Abstract][Full Text] [Related]
73. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Phelps M; Phillips A; Darley M; Blaydes JP
J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837
[TBL] [Abstract][Full Text] [Related]
74. Loss of the deubiquitinase USP36 destabilizes the RNA helicase DHX33 and causes preimplantation lethality in mice.
Fraile JM; Campos-Iglesias D; Rodríguez F; Astudillo A; Vilarrasa-Blasi R; Verdaguer-Dot N; Prado MA; Paulo JA; Gygi SP; Martín-Subero JI; Freije JMP; López-Otín C
J Biol Chem; 2018 Feb; 293(6):2183-2194. PubMed ID: 29273634
[TBL] [Abstract][Full Text] [Related]
75. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
Carón RW; Yacoub A; Zhu X; Mitchell C; Han SI; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):243-55. PubMed ID: 15713896
[TBL] [Abstract][Full Text] [Related]
76. Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras.
Young NP; Jacks T
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10184-9. PubMed ID: 20479239
[TBL] [Abstract][Full Text] [Related]
77. Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.
Zheng Y; Zhao YD; Gibbons M; Abramova T; Chu PY; Ash JD; Cunningham JM; Skapek SX
J Biol Chem; 2010 Nov; 285(46):35654-64. PubMed ID: 20826783
[TBL] [Abstract][Full Text] [Related]
78. Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway.
Fitzgerald EM
J Physiol; 2000 Sep; 527 Pt 3(Pt 3):433-44. PubMed ID: 10990531
[TBL] [Abstract][Full Text] [Related]
79. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
80. Oncogenic H-Ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells. Evidence for association with reactive oxygen species.
Cho HJ; Jeong HG; Lee JS; Woo ER; Hyun JW; Chung MH; You HJ
J Biol Chem; 2002 May; 277(22):19358-66. PubMed ID: 11884408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
